Plazomicin against Multidrug-Resistant Bacteria: A Scoping Review
Plazomicin is a next-generation semisynthetic aminoglycoside antibiotic that can be used to treat infections by multi-resistant bacteria. It is effective against many bacteria-producing carbapenemases or other specific hydrolases. This scoping review aims to define the role acquired by plazomicin fr...
Main Authors: | Aniello Alfieri, Sveva Di Franco, Valerio Donatiello, Vincenzo Maffei, Ciro Fittipaldi, Marco Fiore, Francesco Coppolino, Pasquale Sansone, Maria Caterina Pace, Maria Beatrice Passavanti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/12/1949 |
Similar Items
-
Inhibition of Enzymatic Acetylation-Mediated Resistance to Plazomicin by Silver Ions
by: David Ngo, et al.
Published: (2023-02-01) -
Blood Stream Infections from MDR Bacteria
by: Sveva Di Franco, et al.
Published: (2021-06-01) -
Synergy of Linezolid with Several Antimicrobial Agents against Linezolid-Methicillin-Resistant Staphylococcal Strains
by: María-José Valderrama, et al.
Published: (2020-08-01) -
A Literature Overview of Secondary Peritonitis Due to Carbapenem-Resistant Enterobacterales (CRE) in Intensive Care Unit (ICU) Patients
by: Sveva Di Franco, et al.
Published: (2022-10-01) -
Risk Factors and Outcomes of Acute Graft Pyelonephritis with Bacteremia Due to Multidrug-Resistant Gram-Negative Bacilli among Kidney Transplant Recipients
by: Núria Sabé, et al.
Published: (2022-06-01)